Abstract Individuals with 22q11.2 deletion syndrome (22q11.2DS) have an increased chance of developing a psychiatric disorder. While parents of children affected by 22q11.2DS typically receive counseling about risk for nonpsychiatric health concerns, genetic counselors may be reluctant to discuss psychiatric risk. Further education of genetic counselors may be necessary to encourage discussion of psychiatric risk with these families. The goal of this project was to develop recommendations for genetic counselors to provide psychiatric risk information to families affected by 22q11.2DS. The recommendations were developed by synthesizing resources in the literature about risk communication. These recommendations were refined following an online focus group meeting with five health care professionals who were recruited for participation from 22q11.2DS clinics across the U.S.A. The focus group data revealed three themes related to discussion of psychiatric risk: 1) Stepwise approach, 2) Discussing treatment options and reducing risks, and 3) Addressing stigma. These recommendations may be used as a foundation for a future clinical protocol to encourage discussion about the risk for psychiatric illness at an earlier point in the diagnostic process for 22q11.2DS and to provide improved information, support and resources to affected families.
Introduction
The 22q11.2 deletion syndrome (22q11.2DS) is a complex genetic disorder found in approximately 1 in 4000 individuals (Goodship et al. 1998; Scambler 2000) that affects multiple systems, with features including congenital heart disease, palate abnormalities, learning difficulties, immune deficiency and hypocalcemia. Individuals with 22q11.2DS also have an increased chance of developing psychiatric illness. These risks include psychotic disorders (encompassing the diagnoses of schizophrenia and schizoaffective disorder), mood disorders and anxiety disorders. Risk estimates for schizophrenia or schizoaffective disorder in 22q11.2DS range from 22 to 26 % (Bassett et al. 2005; Fung et al. 2010; Murphy and Owen 2001) , with risk for psychotic disorders in adults with 22q11.2DS estimated at 41 % (Schneider et al. 2014 ). The 22q11.2 deletion syndrome is also associated with increased prevalence of attention deficit hyperactivity disorder in children and increased prevalence of anxiety and mood disorders in adults (Schneider et al. 2014) . Incidence estimates for psychiatric disorders in general in 22q11.2DS range from 42 to 58 % (Bassett et al. 2005; Murphy and Owen 2001) .
While parents of children affected by 22q11.2DS typically receive counseling about risk for non-psychiatric health concerns, they frequently lack sufficient information about the chance for psychiatric illness in their child (Hercher and Bruenner 2008) . A recent study suggests that genetic counselors may be reluctant to discuss this risk due to limited knowledge and stigma related to mental illness (Martin et al. 2012 ). Genetic counselors have been shown to endorse stereotypes about individuals affected by schizophrenia and to express a desire for social distance (Feret et al. 2011) , suggesting stigma may play a significant role in the omission of psychiatric risk from discussion of 22q11.2DS with families. These studies suggest that further education of genetic counselors is necessary to encourage such discussion. Accordingly, the goal of this project was to develop recommendations for genetic counselors to provide psychiatric risk information to families affected by 22q11.2DS. The recommendations were developed by synthesizing resources in the literature about risk communication, with a focus on education about psychiatric disorders and psychosocial issues specific to individuals with 22q11.2DS. They were refined through a focus group meeting with five health care professionals from 22q11.2DS clinics.
Literature Review
In order to develop a preliminary set of recommendations, PubMed.gov was searched for articles related to 22q11.2DS and risk for psychiatric or mental illness. An additional search included articles on the process of psychiatric genetic counseling. Resources were also identified by examining publications cited by relevant papers. The literature review was then organized according to three main topics: (1) a summary of findings on psychosocial issues relevant to individuals and families affected by 22q11.2DS, including emotional experiences and primary concerns of caregivers; (2) literature on methods for psychiatric genetic counseling for individuals with a personal or family history of psychiatric illness; and (3) literature on the impact of stigma related to psychiatric illness on individuals and families in order to inform the recommendations.
Psychosocial Issues
Several studies indicate that families affected by 22q11.2DS experience unique psychosocial issues (involving interacting psychological and social factors) related to the increased chance for psychiatric illness. Hercher and Bruenner (2008) investigated the experience of families affected by 22q11.2DS and found that while a majority of parents were informed about medical manifestations such as heart defects and palate defects, only a minority were informed of their child's risk of psychiatric illness at diagnosis. The majority of parents reported receiving information about psychiatric disorders in 22q11.2DS from non-medical sources, such as the internet. Furthermore, parents had greater anxiety and concerns about the potential for psychiatric illness as compared to other medical manifestations of 22q11.2DS. These findings are supported by a recent survey of parents of children with 22q11.2DS, showing that parents were more likely to receive information about psychiatric manifestations of the condition through the internet than from clinical sources (van den Bree et al. 2013) . The findings support the need for improved access to medical expertise in psychiatric disorders for these families and imply a potential role for genetic counselors to provide support resources and referrals.
Psychosocial issues specific to 22q11.2DS can vary depending on the affected child's stage of development. In addition to risk of schizophrenia, which tends to appear in adolescence or early adulthood, children with 22q11.2DS have an increased chance to develop other psychiatric conditions such as attention deficit disorder, autism spectrum disorder, and mood disorders (Bassett et al. 2011; Schneider et al. 2014) . Parents' concerns for their affected children are also likely to change across developmental stages, with primary concerns for school-aged children focused on finding educational support, encouraging peer relationships, and coping with medical issues (Bassett et al. 2011) . In adulthood, affected individuals' concerns may shift towards maintaining social relationships and employment (Bassett et al. 2011 ). Karas and colleagues (Karas et al. 2012) found that caregivers wished for more information about psychiatric illness and they lacked access to adequate social services for adults with 22q11.2DS. Psychiatric symptoms were the most frequently reported source of difficulty for caregivers. These findings suggest increased education about psychiatric illness for caregivers and affected adults, in addition to improving access to social services, may help to reduce caregiver burden and increase awareness of the importance of early diagnosis and treatment for psychiatric illness.
Psychiatric Genetic Counseling
Recent literature on genetic counseling for individuals with a personal or family history of psychiatric illness provides insights that may be applicable to counseling individuals and families with 22q11.2DS. As the symptoms, age of onset, and treatment response have not been found to differ among individuals with schizophrenia and in those with both 22q11.2DS and schizophrenia , guidelines for general psychiatric genetic counseling may be useful tools when counseling families affected by 22q11.2DS. One strategy psychiatric genetic counselors have employed is to discuss proactive steps individuals can take to decrease environmental risk factors for mental illness, such as stress and use of certain drugs . Genetic counselors may discuss strategies for improved self-care, including stress reduction, ensuring adequate sleep, and avoidance of drugs that might have a role in precipitating psychosis in vulnerable individuals . Additionally, discussing the benefits of early detection may be helpful for patients at risk for psychiatric illness, as earlier detection has been found to be associated with improved prognosis (McGorry et al. 2008 ).
While genetic counselors have expressed concerns about communicating uncertainty in the context of psychiatric illness (Monaco et al. 2010 ), a recent study demonstrated that individuals with psychiatric illness or with affected family members find the genetic counseling process beneficial despite the uncertainty regarding etiology and prognosis (Hippman et al. 2013 ). Peay and colleagues (2008) argue that clients can benefit from being given current understanding of the etiology of a psychiatric disorder, even if the current scientific basis is not well-understood. Genetic counselors are in a position to help clients by providing anticipatory guidance about possible outcomes and by discussing psychiatric illness in a similar manner to other complex disorders . As families affected by mental illness experience devastating feelings of ongoing loss, genetic counselors can be helpful by responding with empathy and expressing an appreciation for the impact of the condition on the family (Lautenbach et al. 2012) . These roles for genetic counselors are likely to apply when counseling individuals and families affected by 22q11.2DS; they can help to address the uncertainty and complex nature of the potential for psychiatric illness in affected individuals.
Stigma
Stigma associated with psychiatric illness plays an important role in how psychiatric symptoms are experienced by families affected by 22q11.2DS. Families affected by mental illness may experience profound feelings of guilt and shame related to the condition, which can significantly impact the affected individual's self-esteem and lead to decreased support and isolation among family members (Austin and Honer 2005) . Families at risk for mental illness may experience Banticipatory stigma,^or different treatment of a child with increased risk due to fears of psychiatric illness (Austin and Honer 2005) . Parents may also avoid publicly discussing their child's condition due to concerns about how their child will be judged or feared by others (Lautenbach et al. 2012) . These concerns are also relevant in families affected by 22q11.2DS, although having a genetic diagnosis may help to alleviate some of the potential stigma and blame associated with their child's psychiatric symptoms . However, the stigma associated with psychiatric illness remains as a significant concern as parents of children with 22q11.2DS report concerns about others treating their child differently due to their mental illness (Hercher and Bruenner 2008) .
Stigma may also play an affect the likelihood that health care professionals will disclose risk for psychiatric illness to families affected by 22q11.2DS. Martin et al. (2012) surveyed genetic counselors and found that the majority did not disclose risk for psychiatric disorders at the time of diagnosis, particularly when diagnosis was during infancy (Martin et al. 2012) . A majority of their respondents reported stigma as a factor in their decisions about disclosure of increased chance for psychiatric illness. In a study by Feret and colleagues (2011) , the researchers hypothesized that stigma plays an important role in genetic counselors' attitudes about schizophrenia. They found that genetic counselors preferred greater social distance from people with schizophrenia in more intimate scenarios and endorsed more negative than positive characteristics toward people with schizophrenia. These findings imply that genetic counselors would benefit from greater awareness of their potential biases when counseling individuals affected by psychiatric illness, as counselors' their attitudes may negatively influence their rapport with the client and bias them against discussion of psychiatric risk information that would benefit affected families.
Given the concerns of families affected by 22q11.2DS about risk for psychiatric illness and the lack of adequate information given to families, genetic counselors may benefit from having a set of recommendations to improve the counseling process and help families receive credible risk information at an earlier stage of the diagnostic process. This report describes a set of preliminary recommendations developed based on the literature described above to guide genetic counselors in discussing psychiatric risk with families affected by 22q112DS. These recommendations were assessed in a focus group meeting with health care professionals who work with families affected by 22q11.2DS in order to refine and provide further guidance for their development.
Method Design
Following development of an initial draft of recommendations for psychiatric risk communication in 22q11.2DS, a single online focus group session was conducted with health care professionals to refine the proposed recommendations.
This study was approved by the Institutional Review Board at the University of North Carolina at Greensboro.
Participants
Initial recruitment letters were sent to health care professionals from nine 22q11.2DS clinics across the U.S.A. Clinics were identified by internet search of support groups related to 22q11.2DS. Individuals from the different 22q11.2DS clinics were requested to forward a recruitment letter to other members of the clinic. Seven of the nine clinic contacts agreed to forward the recruitment letter, one clinic contact declined to participate, and one contact did not respond. Following dissemination of the recruitment letter, a total of eight individuals responded to an online survey providing their contact and demographic information. Participants were considered eligible for participation in the focus group if they had provided care in the past year for at least one individual with 22q11.2DS. Prior to the focus group, information was obtained from each participant about their area of practice, with options to select BM.D. geneticist,^Bgenetic counselor,B M.D.-other,^or BOther,^with a box for participants' selfreported area of practice. Information was also obtained on the number of years of experience in their professions and an estimate of the number of patients with 22q11.2DS seen in the past year.
Five of the eight survey respondents were able to schedule a time to participate in the focus group. The participants included one geneticist (M.D.), two child psychiatrists (M.D.), one genetic counselor, and one liaison/coordinator. The participants had an average of 12 years of experience (S.D. = 10.05 years, Range: 3-25 years) and saw either a range of 11-20 patients (two participants) or greater than 20 patients with 22q11.2DS in the past year (three participants).
Procedures
Prior to the focus group meeting, participants received electronic copies of the initial draft of recommendations for psychiatric risk communication in 22q11.2DS. They also were informed that the goal of the focus group was to obtain feedback on topics related to the set of recommendations in order to improve the genetic counseling process for discussing the risk for psychiatric illness with families affected by 22q11.2DS.
The focus group session was conducted through audioconferencing using GoToMeeting software (Citrix Systems, Inc.), which also included audio recording of the session.
The duration of the focus group was one hour. The focus group was moderated by the principal investigator, and one additional member of the research group participated as an observer. The focus group included discussion of several introductory and transition questions, followed by presentation of key questions related to recommendations for psychiatric risk communication. The questions were displayed on a PowerPoint presentation during the session.
Instrumentation
An interview guide was developed for the focus group. There were three introductory and transition questions: 1) Do you typically discuss psychiatric risk with families affected by 22q11.2DS? If so, at what point in the diagnostic process do you discuss it? 2) What type of language do you prefer for describing psychiatric risk in 22q11.2DS? For example, do you prefer to describe a risk of Bschizophrenia,^Bpsychosis,ô r prefer more general terms? and 3) What do you feel are the major barriers to discussing psychiatric risk with families affected by 22q11.2DS? There were four key questions: 1) When and how do you think that information about the risk for psychiatric illness should ideally be provided to families? 2) Are there times that you feel that psychiatric risk should not be discussed? 3) When educating clients about psychiatric illness in 22q11.2DS, what information about psychiatric illness do you feel would be the most beneficial to families? and 4) Studies have shown that stigma among health care providers towards individuals with mental illness may affect their likelihood to disclose psychiatric risk. How do you think that stigma towards mental illness should be addressed?
The session concluded with an ending question: Is there anything that you feel should be recommended to other health care providers about psychiatric risk in 22q11.2DS that we did not discuss?
Data Analysis
Following the focus group session, the full audio recording was transcribed. Each transcribed quote was analyzed qualitatively by the first author using methods as described by Krueger and Casey (2009) . The compiled quotes for each focus group question were summarized and quotes were then categorized according to themes. A second investigator also agreed upon the identified themes and the categorization of each quote, with no changes suggested to the original categorizations. Individual quotes were selected for illustrative purposes for each theme.
The initial set of recommendations for psychiatric risk communication in 22q11.2DS was then revised according to the opinions of the focus group participants. Participants were provided with electronic copies of the revised recommendations.
Results

Focus Group Themes
The analysis of the focus group data revealed three themes related to discussion of psychiatric risk: 1) Stepwise approach, 2) Treatment and reducing risks, 3) Addressing stigma. Each of these themes will be discussed below with representative quotes used for illustration.
Theme 1: Stepwise Approach
Participants in general endorsed a stepwise approach for communicating psychiatric risk information to families affected by 22q11.2DS, with some initial information being presented at the time of diagnosis and more information presented at follow-up sessions. In general, participants agreed that discussion of chance for psychiatric illness earlier in the diagnostic process was best. Because it could be difficult to have families return for follow-up sessions, it was important that families receive some information about early signs to look for and that they be made aware they should seek attention from a specialist if they perceived changes in their child.
One participant felt it was particularly critical that families receive psychiatric risk information early because she felt that the management for 22q11.2DS tends to increase stress levels and susceptibility to psychiatric illness in affected children. She commented:
I have a real big issue that we focus so much on the medical and on the developmental and you kind of collude with the family that if you just put them through enough extra therapies, enough extra tutoring, you can turn them back into the perfect non-22q child they were meant to have. And you actually put a child who is at risk for mental illness…under a lot of stress. And so I actually discuss with families the importance of mental health from an early standpoint.
This participant also felt that it was best to introduce the terms as early as possible to help maintain a trusting relationship between families and providers. She commented on her perception of the perspective of a parent with an affected child:
…I know, if somebody didn't tell me about [psychiatric risk], and I'm trusting you to guide me through this condition and you don't tell me about that, then, every time I'm coming to see you I'm thinking, alright, what else didn't you tell me?…What other bomb are you going to drop on me later?
Participants also generally felt the chance for psychiatric illness should be disclosed at the time of diagnosis in most situations, unless the child's prognosis is so poor that it would be inappropriate to discuss any long-term issues of the condition. In general, participants felt that if it was not appropriate to discuss longer-term concerns like speech delays, it was not appropriate to discuss the risk for psychiatric illness. In every other situation, participants felt that it was important to mention psychiatric risk to families. One participant commented: 'If you're not even going to talk about developmental delay, or speech delay because of the situation then, you're…in such a different sort of situation that…you wouldn't mention [psychiatric risk]. But otherwise, why wouldn't you mention it?' This participant felt that even when there were many medical issues to be dealt with, it was still important to mention the later onset concerns and to reassure families that psychiatric illnesses are treatable.
Theme 2: Treatment and Reducing Risks
Several participants agreed that one of the most important pieces of information to convey to families is not only what psychiatric illnesses they were at risk for, but also what could be done to treat them. Participants also felt that information about reducing the chance for psychiatric illness should be provided in a way that does not make parents feel they are to blame. It was important that psychiatric illness be treated similarly to other medical conditions like diabetes, where families could be provided a list of things to do to modulate the risks. Participants mentioned educational interventions, social support, and a rich intellectual environment as potentially useful ways to reduce risk for developing psychiatric illness.
Participants also agreed that taking steps like improving social skills as much as possible would be valuable for reducing risks. One participant expressed concern about families finding time for focusing on social skills, and commented:
…My concern is that we can get parents too hung up on passing those proficiency tests so that…there's not time for a social skills group because [of]…speech and tutoring. And I think telling families that those social skills groups, and some of those other things, are actually potentially more important for their lifelong health… Additionally, participants agreed that it was helpful for families to establish a relationship with a mental health provider during the pre-adolescent years, so that if psychiatric concerns arose later in the teenage years, they would have a provider in place that was already familiar with the child and could better address concerns about potential changes in behavior.
Theme 3: Addressing Stigma
Participants identified stigma about psychiatric illness and genetic counselors' lack of comfort and lack of exposure to people with mental illness as major barriers to discussing psychiatric risk with affected families. They felt that by introducing psychiatric illnesses as treatable conditions, stigma could be reduced. One participant commented:
…I don't think there is much effort really to make people comfortable with their knowledge of mental illness. So you're talking about something that you're not comfortable with…I don't think the average genetic counselor can really confidently portray it as a treatable condition. And if you can't portray it as a non-terrifying treatable condition, then how can you help a family feel that way about it?
Participants felt that if health care providers were uncomfortable with discussing psychiatric risk, they needed to take steps to increase their comfort. One idea included the possibility for genetic counseling training programs to include some face-to-face time with individuals with schizophrenia to increase their comfort levels. Other ideas included educational materials for providers including basic, recently updated information about schizophrenia, in addition to standard protocols to consistently discuss risk for psychiatric illness with all affected families. One participant suggested that providers who feel reluctant to discuss psychiatric risk should talk with a colleague and practice their approach to help overcome their own fears. She felt that a good approach is to use the same strategy as for discussing any medical symptom: BI just think, substitute the word Bschizophrenia^or Banxiety disorder^for the word Bdiabetes^or Bhypothyroidism^or Bhypocalcemia,â nd you will be pretty close to what you should be doing^.
General Recommendations for Psychiatric Risk Communication in 22q11.2DS
Based on the focus group findings, the initial set of recommendations for genetic counselor psychiatric risk communication in 22q11.2DS were modified to include additional points participants identified as important. The recommendations are presented below. Some studies have indicated that families affected by 22q11.2DS lack reliable information about the risk for psychiatric illness and receive the majority of their information from the internet rather than from clinicians (Hercher and Bruenner 2008; van den Bree et al. 2013) . Reliance on the internet as the primary source of information may prevent families from obtaining appropriate follow-up and referrals. Parents of children affected by 22q11.2DS have expressed a preference to have psychiatric risk information presented to them by a team of health care professionals, with the opportunity for followup appointments (Martin et al. 2012) . In order to provide the best access to multi-disciplinary expertise and follow-up, patients should be referred to 22q11.2DS specialty clinics whenever possible (Bassett et al. 2011) . These clinics can provide support for both parents and clinicians, facilitate access to peer-support networks, and provide ongoing monitoring of an affected individual's mental health to allow for early intervention (Bassett et al. 2011 ). The 22q11.2DS clinics have also been found to be the most likely medical source to provide psychiatric risk information to patients and families, in comparison to other medical professionals (Hercher and Bruenner 2008) . In addition, families should be provided with internet resources with clinical and scientific information that has been appropriately evaluated, but it should be emphasized that these resources should not replace ongoing interactions with health care providers (van den Bree et al. 2013 ). Because 22q11.2DS clinics may be geographically available to an affected family, it is important to explore potential referrals to psychiatrists or other mental health professionals who are familiar with 22q11.2DS. Families affected by 22q11.2DS need access to expertise in a range of psychiatric illnesses, as the condition can be associated with not only psychosis, but also childhood-onset disorders such as ADHD, autism spectrum disorders, and anxiety/depressive disorders (Bassett et al. 2011; Schneider et al. 2014 ). It may be particularly helpful to assist affected families with preadolescent aged children to establish a relationship with a mental health provider (e.g., psychiatrist or psychologist). If psychiatric concerns then arise during adolescence, having an established relationship with a mental health provider may be helpful when addressing any potential changes to behavior. However, awareness about 22q11.2DS may be limited in the psychiatric community, and establishing a relationship with a mental health provider may be not feasible for individuals without diagnosed psychiatric illness or with limited resources. Therefore, it is important that genetics professionals take the lead in providing psychiatric risk information and resources for affected families.
Recommendation 2: Present Psychiatric Risk Information at the Time of Diagnosis, with Further Information Provided at Follow-up Visits
Families have expressed a need for information about risk for mental illness earlier in the diagnostic process, especially prior to the onset of potential psychiatric symptoms (Martin et al. 2012) . Although genetic counselors may feel uncomfortable with discussion of psychiatric risk, particularly when a child is diagnosed in infancy (Martin et al. 2012) , it is important that families receive this information from a health care provider rather than through their own search of the internet. Considering that affected families may not always return for follow-up visits, a potential strategy involves providing limited information about risk for psychiatric illness at the time of diagnosis (more extensive information can be presented later to those families that do attend follow-up sessions). This strategy involves giving families a basic introduction to the topic of psychiatric risk. While the initial information need not be in-depth at the time of diagnosis, it is important that families receive the information in a sensitive manner and with emphasis on the potential for treatment. A potentially useful strategy is to implement a standard protocol in which psychiatric risk is consistently discussed with every family affected by 22q11.2DS. Genetic counselors should also recommend that psychiatric, behavioral and emotional assessments be carried out at each stage of development, including at the time of diagnosis, preschool age, school age, adolescence, and adulthood (Bassett et al. 2011) . Follow-up visits are critical in providing continuing assessments and information for families, as new symptoms may appear throughout the lifespan of an affected individual.
Recommendation 3: Provide a Balanced Description of the Roles of Genes and Environment in Precipitating Psychiatric Illness
While symptoms of psychosis or schizophrenia may be largely attributed to genetic causes in 22q11.2DS, it is also important to discuss the role of environmental factors in the risk for psychiatric illness. Austin and Honer (2007) found that attribution of mental illness to genetic causes may be associated with pessimism about the effectiveness of treatments and decreased hope of recovery. Affected families may not be aware of potential environmental contributions that can modulate risk for psychiatric illness. However, discussion of environmental factors can potentially lead to feelings of guilt about what family members could have done to contribute to or prevent the illness (Austin and Honer 2007) . Therefore, it is critical to explore the client's emotions related to the risk for psychiatric illness in their child and to present information about environmental factors in a sensitive and balanced manner.
It is also important for families to understand not only the risks for developing psychiatric illness, but also the chances that the individual will not develop psychiatric illness. Families may experience anxiety or treat a child differently based on their risk (anticipatory stigma), when the child with 22q11.2DS does not subsequently develop psychiatric illness. Presenting risk information in multiple formats (known as Bframing^in the genetic counseling process) may be helpful to aid in families' understanding of the risk (Baty 2009 ), in addition to acknowledging the role of emotions in how risk figures are perceived (Lautenbach et al. 2013) .
When describing the current knowledge of the pathogenesis of psychiatric illness in 22q11.2DS, genetic counselors should use lay language with visual aids, if possible (Austin and Honer 2007) . A useful tool published by the National Society of Genetic Counselors for describing the etiology of mental illness is the Bjar^model, which uses a visual aid of a jar filled with symbolic genetic factors and environmental factors (BMental illness: Underlying causes and approaches for recovery^2012). A full jar corresponds to an individual having symptomatic mental illness. This model can be used in the 22q11.2DS population to show that while genetic factors significantly increase risk for mental illness, a person with high genetic risk will not necessarily develop mental illness. The model can also be used to illustrate that while individuals with high genetic risk factors may be more susceptible to effects of stress or other environmental factors, some of these factors can be Bremoved^from the jar through stress management and modifying lifestyle risk factors. While there may not be a way to directly prevent psychiatric illness, risk can be reduced by taking steps such as providing educational interventions, social support and a rich intellectual environment. Following these explanations, genetic counselors should explore the client's perception of the risk for psychiatric illness in order to address any potential feelings of fatalism, hopelessness or guilt (Austin and Honer 2007) .
Recommendation 4: Provide Families Affected by 22q11.2DS with Information About Available Treatments and Management Strategies for Psychiatric Illness
When describing the risk for psychiatric illness in 22q11.2DS, this information should be provided in the context of information about available treatments, early intervention programs, and the importance of early awareness and detection of symptoms Hercher and Bruenner 2008) . Genetic counselors can discuss with families how early detection of potential symptoms is associated with a better prognosis (Martin et al. 2012; McGorry et al. 2008) . Families can also be informed about practical steps to avoid exposure to triggers for psychiatric illness, such as stress management, good nutrition, avoiding alcohol, and ensuring adequate sleep Martin et al. 2012) . Avoiding particular drugs, such as cannabis and methamphetamine, is important for individuals with increased risk for psychiatric illness, as these drugs have been associated with triggering episodes of psychosis . It may also be helpful to discuss psychosocial intervention programs, which have been shown to be helpful in educating families about mental illness and improving family well-being (Austin and Honer 2007; McFarlane et al. 2003) . Focusing on developing social skills may be particularly valuable in reducing risks and improving lifelong health. While these measures may modulate psychiatric risk, providers should also communicate that these interventions may or may not reduce risk for a particular individual. Families should know that development of psychiatric illness in their child does not indicate that caregivers failed to prevent the condition.
Genetic counselors can help to make parents aware that they should contact their family doctor with any behavioral concerns, in order to facilitate referral for a psychiatric specialist (van den Bree et al. 2013) . Additionally, genetic counselors can provide information about management and resources for 22q11.2DS directly to families' local providers (Bassett et al. 2011 ), or to families themselves so that they can help to educate other health care providers who may be less familiar with 22q11.2DS (Karas et al. 2012) . Provision of educational resources to share with other providers may help to increase awareness of the psychiatric risk associated with the condition and help identify symptoms early. Additionally, it is important that mental health providers know the treatment strategy and medications for psychiatric illness in 22q11.2DS are the same as for psychiatric illness in the general population. The risk for psychiatric illness in 22q11.2DS has been found to cause the most amount of anxiety in parents in comparison to risks for other medical issues (Hercher and Bruenner 2008) . The uncertainty of not knowing whether and how psychiatric problems will arise causes a tremendous amount of stress in parents. They may be very vigilant about their child's behavior and may have difficulty in distinguishing between normal and abnormal behavior (Hercher and Bruenner 2008) . Parents of children with mental illness have also been found to experience profound feelings of chronic loss (Lautenbach et al. 2012) . It is important, therefore, to address parents' feelings of anxiety and loss directly and to normalize their experiences. Genetic counselors are also in a position to help parents restructure feelings of guilt (Austin and Honer 2007) , as they may worry they could have contributed to their child's risk for mental illness (Lautenbach et al. 2012) . Genetic counselors can also assess clients' perceived sense of burden or adversity ) and discuss coping strategies to help increase sense of personal control, such as collecting information about the condition (Hippman et al. 2013) .
It is important that families are provided with support resources to help them cope with their emotions and to connect with other families with similar experiences. These resources are available through 22q11.2DS clinics and formal organizations. Additionally, connecting families with formal organizations or societies may help them acquire social services, which have been found to be lacking in adults affected with 22q11.2DS (Karas et al. 2012) . Examples of these organizations include the International 22q11.2 Deletion Syndrome Foundation (www.22q.org) and the Velo-Cardio-Facial Syndrome Education Foundation (www.vcfsef.org).
Recommendation 6: Directly Address the Role of Stigma in Clients' Feelings About Psychiatric Illness
Stigma related to psychiatric illness has a significant impact on affected families and their relationships with others (Austin and Honer 2005) . Parents of children with 22q11.2DS have expressed concerns about keeping their child's diagnosis private due to the increased risk for psychiatric illness and fears that the child will be seen differently (Hercher and Bruenner 2008) . It may be helpful for genetic counselors to directly discuss families' experiences and concerns with stigma and demonstrate comfort with such discourse (Lautenbach et al. 2012) . By discussing psychiatric disorders in the same manner as any other disorder, genetic counselors can make families feel more comfortable with the topic of risk for mental illness . Genetic counselors may also want to discuss the potential impact of awareness of their child's psychiatric risk on their interactions. Some families with at-risk children may experience anticipatory stigma, or treating the child differently based on fears of mental illness (Austin and Honer 2005) . Genetic counselors may have the opportunity to normalize clients' feelings and increase awareness of how stigma may impact the family dynamic.
Recommendation 7: Genetic Counselors Should Assess Their Own Feelings of Stigma Toward Individuals with Psychiatric Illness
Genetic counselors may benefit from exploring their own thoughts and feelings about psychiatric illness, as their reactions are likely to affect rapport with families ). There are several tools available for self-assessment of stigmatizing attitudes, including Day's Mental Illness Stigma Scale (Day 2003 ) and the Mental Illness: Clinicians' Attitudes Scale (MICA-4) (Gabbidon et al. 2013) . Additionally, there are several available videos illustrating personal stories of psychiatric illness that may influence attitudes (Anderson and Austin 2012; Maxwell 2012) . By increasing awareness of one's own potentially stigmatizing attitudes and taking advantage of potential educational opportunities about psychiatric illness, genetic counselors may improve their services to affected individuals and families. Additionally, discussing with colleagues how to approach psychiatric risk and practicing one's counseling approach may be helpful in overcoming feelings of stigma toward psychiatric illness.
Recommendations for Specific Groups of Individuals 1) Provide adolescents with 22q11.2DS their own counseling sessions to discuss psychiatric risk. As adolescence is a particularly vulnerable stage for the appearance of psychiatric symptoms, genetic counselors should provide adolescents with 22q11.2DS with their own counseling sessions to explain the importance of identifying early behavioral changes and to discuss treatment and support options that are available if psychiatric symptoms appear (van den Bree et al. 2013) . It is also important to assess whether the adolescent client is engaging in potentially risky behaviors, such as drug or alcohol abuse, as well as assessing any recent changes in behavior (Bassett et al. 2011) . Follow-up visits are especially important at the stage of transition from adolescence to adulthood, when concerns about psychiatric issues may be particularly prominent (Bassett et al. 2011) .
2) When an individual with 22q11.2DS is affected with a psychiatric illness, provide psychosocial counseling and support and educational resources to both the affected individual and to the individual's family members. Psychosocial genetic counseling involves exploring clients' emotions, beliefs, and processing of risk information (Weil 2002) . When providing counseling to adults with 22q11.2DS affected with psychiatric illness, it may be helpful to explore their feelings about their illness, as having fatalistic beliefs may correlate with risky behaviors (Austin and Honer 2007) . It is also important to explore their coping strategies and assess any potential symptoms of depression or feelings of hopelessness, as individuals with schizophrenia have been found to have an increased risk for suicidal behavior (Radomsky et al. 1999) . Genetic counselors can provide referrals and support for individuals that may need additional resources to help them cope with psychiatric illness.
It is also important that genetic counselors provide support and educational resources for caregivers. Caregivers of adults with 22q11.2DS have reported having insufficient knowledge of psychiatric conditions and a desire for more information about the onset of mental illness (Karas et al. 2012) . Genetic counselors should also encourage all members of the family to participate in the counseling session to address their feelings and provide education about psychiatric illness. In particular, siblings may receive little support and may experience strong feelings of guilt associated with a brother's or sister's condition (Austin and Honer 2007) . Encouraging participation by the whole family may help to alleviate feelings of guilt and shame.
3) For parents affected with 22q11.2DS, assess mental health and tailor risk communication to the client's cognitive capabilities. For parents who are affected with 22q11.2DS and who also have an affected child, it is important to assess mental health (Bassett et al. 2011) and to provide resources such as social support options . When discussing psychiatric risk with parents who are affected with cognitive impairment, it may be helpful to focus the session more on psychosocial issues rather than on providing a detailed discussion of probability and risk (Finucane 2010) . Finucane suggests minimizing use of analogies to illustrate concepts and, with the client's permission, involving their support system in the counseling session. When counseling parents affected with 22q11.2DS and psychiatric illness, it may also be appropriate to consider involving a mental health professional in the counseling session in order to best address the needs of the client (Finucane 2010) .
4) When recently diagnosed infants with 22q11.2DS are in a medically fragile state, disclose psychiatric risk information in intervals and identify strategies to facilitate follow-up visits. When an infant has recently been diagnosed with 22q11.2DS, families may often be coping with difficult medical issues such as heart defects or surgeries related to cleft lip or palate. Health care professionals have reported concerns with overwhelming parents with too much information, especially when psychiatric issues are not immediately relevant for the child's care (Martin et al. 2012; Morris et al. 2013; van den Bree et al. 2013) . Van den Bree and colleagues (2013) note that while there is a possibility of overwhelming parents with too much information, it is still important that information about psychiatric risk be available to families early in the diagnostic process. While it may not be appropriate to discuss this risk in an infant with a very poor prognosis, in cases where it is deemed appropriate to discuss any longer-term concerns like speech delay, psychiatric risk should also be mentioned. It may be helpful to take parents' emotional state into account and assess whether they may wish to discuss all possibilities or only the most salient information (Martin et al. 2012) . Disclosing risk information in intervals may be helpful, by providing some basic information about psychiatric risk at diagnosis and emphasizing the importance of follow-up visits (Martin et al. 2012; Morris et al. 2013) . It may also be helpful to identify strategies to facilitate follow-up visits, as they may be a significant factor in determining whether families learn about psychiatric risk from a health care professional as opposed to the internet (Morris et al. 2013) .
Discussion
This project describes a set of recommendations for genetic counselors for communicating psychiatric risk information to families affected by 22q11.2DS. These recommendations were developed based on a review of the literature and findings from a focus group of health care professionals who work with affected families. The final set of recommendations includes detailed suggestions about how to discuss psychiatric risk with affected families, including the timing of the discussion relative to the time of diagnosis and specific information to be communicated with families.
Focus group participants expressed that psychiatric risk information would be best disclosed to families in a stepwise manner, with some general information presented at the time of diagnosis and more specific information presented at follow-up sessions. Their views are similar to those of van den Bree and colleagues (2013), suggesting that childhoodonset issues be discussed at the time of diagnosis with lateronset issues discussed at follow-up sessions. However, the focus group participants also asserted that parents should receive some information about all long-term issues, including psychiatric illness, at the time of diagnosis. Rather than presenting different types of risk information over time, the consensus of the focus group participants was that it could be helpful to vary the quantity of information and level of detail about psychiatric illness depending on the developmental stage and time of diagnosis.
The recommendation that some psychiatric risk information be provided at the time of diagnosis is supported by reports from parents of affected children about their preferences for receiving risk information (Martin et al. 2012) . Parents felt that having this information would help them adjust emotionally and be proactive in managing their child's condition by addressing early signs and starting early treatment. As discussed in the focus group, because families would likely read about psychiatric illness on the internet, it is important that they receive relevant information from a trusted and expert source.
Focus group members also stressed the importance of conveying information about the management and treatability of psychiatric illness when discussing risk with affected families. They emphasized treating psychiatric illness in an analogous way to other medical conditions, specifically, providing a list of management and treatment strategies. Participants mentioned discussing important strategies with families, including educational interventions, a rich intellectual environment, and social support. Social skills, in particular, were emphasized as being important for individuals with 22q11.2DS. These recommendations are consistent with psychosocial interventions for schizophrenia that are designed to improve social competence; and they may be particularly helpful when combined with training for attention skills (Mueser et al. 2013) . Mueser et al. (2013) also identified beneficial interventions that included healthy lifestyle interventions, cognitive remediation, and family psychoeducation. As chronic stress has also been linked to increased susceptibility to psychiatric illness in adulthood, developing stress coping skills to address childhood anxiety may also be an important tool to help to mitigate the risk for psychosis (Beaton and Simon 2011) .
Finally, focus group participants identified stigma toward mental illness as a major barrier to discussing psychiatric risk and asserted that portraying mental illness as a treatable condition would help to decrease stigma. Their opinions are compatible with other authors' suggestions that stigma may be reduced if genetic counselors demonstrate comfort with discussion of psychiatric risk and treat mental illness similarly to other conditions (Lautenbach et al. 2012; Peay et al. 2008 ). The present participants suggested several specific strategies to address stigma among health care providers, including increasing interaction with individuals with psychiatric illness in genetic counseling training programs, providing educational materials for providers, and encouraging providers to practice approaches to discussing psychiatric risk with colleagues.
Study Limitations and Research Recommendations
This project to develop recommendations for psychiatric risk communication in 22q11.2DS had several limitations. As this project did not employ quantitative methods and was limited to a single, one-hour focus group format, with only five participants, the findings cannot be generalized to the general population of healthcare providers. Use of a single group makes it impossible to determine whether data saturation was obtained; a minimum of three groups is recommended to reach data saturation (cf. Krueger and Casey 2009) . Moreover, the one-hour time limit precluded an investigation of participants' opinions or level of agreement about the appropriateness of each recommendation. Based on the recruitment strategy of focusing on 22q11.2DS clinics, the sample of participants was likely biased towards providers with a strong interest in psychiatric risk in 22q11.2DS. It is possible that health care professionals with different areas of practice would have differing opinions on the best way to discuss risk for psychiatric illness in 22q11.2DS. Additionally, as the current study was limited in scope, it did not include ascertainment of the opinions of individuals and families affected by 22q11.2DS on how they would best prefer to receive psychiatric risk information. Inclusion of these individuals in future studies would be useful to determine the types of information families would prefer to receive over time relative to their child's diagnosis. Furthermore, future studies could assess opinions of caregivers and adults with 22q11.2DS on how and at what age to discuss psychiatric risk directly with affected individuals. Finally, additional research could investigate the opinions of healthcare professionals about psychiatric risk communication using quantitative methods, to determine appropriateness and feasibility of specific recommendations in practice.
Practice Implications
The publication of these proposed recommendations may be used to inform development of a clinical protocol to enhance the genetic counseling process for families affected by 22q11.2DS. A clinical protocol could be used by healthcare professionals to facilitate discussion about the risk for psychiatric illness at an earlier point in the diagnostic process and improve the provision of information, support and resources to affected families.
Human Studies and Informed Consent All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all participants for being included in the study. Additional informed consent was obtained from all participants for which identifying information is included in the acknowledgement section of this article.
